If it's bad do you want him to release it if he's not legally required to? It's his job to help us survive until a deal if possible. For a company in our position it means apply full spin on everything. It's for the good of all IPIX shareholders.
If Brilacidin for COVID doesn't work, at least this volume and price strength is going to help us survive to whatever deal we can put together for the other assets. If it just pays for what we may owe Dr. Menon and Cummings then it served its purpose.
That's why I always reiterate that I shudder to think where we would be without COVID.
"The lead researchers at both the RBL and at the PHRI have informed the Company they plan to submit their findings, separately, upon completion of in vitro testing, for peer-review publication."
I would think with these research labs committing to a peer review would limit information out ahead of it. I imagine we'll pickup more news before testing ends.
News 
Market Data 
Discover 
